Neurology Central

NS1-based Zika vaccine demonstrates promise in mice

Research presented at the American Society for Microbiology Microbe 2017 conference (1–5 June, LA, USA) has reported a novel Zika vaccine, which can induce 100% protection in mice after a single dose. This is the first vaccine to be based on the Zika virus non-structural protein 1 (NS1).
To view restricted content, please:

Leave A Comment